Not Yet RecruitingNot Applicable

Assessing Psoriasis Treatment Outcomes

United States15 participantsStarted 2026-07

Plain-language summary

To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ≥18 years of age * Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD) * Patients who live in the United States * Patients with a sufficient command of the English language * Patients with a mobile device able to at least operate at 25 frames per second (FPS). Exclusion Criteria: * Patients less than the age of 18 * Patients with severe or unstable comorbid conditions * Patient who are pregnant or breastfeeding * Patients with any other skin conditions that prohibit or confound the ability of the investigator to interpret skin findings * Patients that are taking concomitant topical or systemic therapy for the treatment of psoriasis and/or phototherapy * Patients without mobile devices able to at least operate at 25 frames per second (FPS). * Patients without a current diagnosis of psoriasis suitable for treatment with topical BD

What they're measuring

Ability to implement AIGPP system and Rate of dropout in AIGPP trial arm

Timeframe: Week 4

Thematic analysis of qualitative interviews regarding psoriasis patients' attitudes, trust, and comfort levels with AIGPP interactions in a healthcare setting

Timeframe: Week 4

Trial details

NCT IDNCT07391423

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12

Contact for this trial

Irma M Richardson, MHA

336-716-2903 irma.richardson@advocatehealth.org